213 related articles for article (PubMed ID: 29140658)
1. Killing U.S. Slowly: Curing the Epidemic Rise of Cancer Drug Prices.
White EK
Food Drug Law J; 2017; 72(1):189-224. PubMed ID: 29140658
[TBL] [Abstract][Full Text] [Related]
2. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Kesselheim AS; Avorn J; Sarpatwari A
JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
[TBL] [Abstract][Full Text] [Related]
3. Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards.
Bendicksen L; Rome BN; Avorn J; Kesselheim AS
Milbank Q; 2021 Dec; 99(4):1162-1197. PubMed ID: 34375015
[TBL] [Abstract][Full Text] [Related]
4. How Medicare could get better prices on prescription drugs.
Outterson K; Kesselheim AS
Health Aff (Millwood); 2009; 28(5):w832-41. PubMed ID: 19643778
[TBL] [Abstract][Full Text] [Related]
5. Implications of Proposed Medicare Reforms to Counteract High Cancer Drug Prices.
Mailankody S; Prasad V
JAMA; 2016 Jul; 316(3):271-2. PubMed ID: 27149663
[No Abstract] [Full Text] [Related]
6. Paying for On-Patent Pharmaceuticals: Limit Prices and the Emerging Role of a Pay for Outcomes Approach.
Fuller RL; Goldfield N
J Ambul Care Manage; 2016; 39(2):143-9. PubMed ID: 26945298
[TBL] [Abstract][Full Text] [Related]
7. Rx: higher prices.
Kosterlitz J
Natl J (Wash); 1993 Feb; 25(7):396-9. PubMed ID: 10125572
[TBL] [Abstract][Full Text] [Related]
8. Rising Cost of Anticancer Medications in the United States.
Jackson K; Nahata MC
Ann Pharmacother; 2017 Aug; 51(8):706-710. PubMed ID: 28707550
[TBL] [Abstract][Full Text] [Related]
9. Regulating Drug Prices while Increasing Innovation.
Conti RM; Frank RG; Gruber J
N Engl J Med; 2021 Nov; 385(21):1921-1923. PubMed ID: 34767322
[No Abstract] [Full Text] [Related]
10. Reducing Branded Prescription Drug Prices: A Review of Policy Options.
Alexander GC; Ballreich J; Socal MP; Karmarkar T; Trujillo A; Greene J; Sharfstein J; Anderson G
Pharmacotherapy; 2017 Nov; 37(11):1469-1478. PubMed ID: 28805961
[TBL] [Abstract][Full Text] [Related]
11. Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.
Kanavos P; Ferrario A; Vandoros S; Anderson GF
Health Aff (Millwood); 2013 Apr; 32(4):753-61. PubMed ID: 23569056
[TBL] [Abstract][Full Text] [Related]
12. Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues.
Dusetzina SB; Mello MM
N Engl J Med; 2018 Dec; 379(24):2290-2293. PubMed ID: 30428275
[No Abstract] [Full Text] [Related]
13. Should the United States government regulate prescription prices? A critical review.
Patterson JA; Carroll NV
Res Social Adm Pharm; 2020 May; 16(5):717-723. PubMed ID: 31248779
[TBL] [Abstract][Full Text] [Related]
14. Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged.
Levy MS
Am Univ Law Rev; 2016; 66(1):247-303. PubMed ID: 28225582
[TBL] [Abstract][Full Text] [Related]
15. Rebates-The Little-Known Factor Behind Increasing Drug List Prices.
Rubin R
JAMA; 2020 Mar; 323(9):812-813. PubMed ID: 32125400
[No Abstract] [Full Text] [Related]
16. AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0).
Academy of Managed Care Pharmacy
J Manag Care Pharm; 2009 Aug; 15(6 Suppl A):S3-57, quiz S58-61. PubMed ID: 19678720
[TBL] [Abstract][Full Text] [Related]
17. How insurers' bargaining power affects drug prices in Medicare Part D.
Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274
[No Abstract] [Full Text] [Related]
18. [Medication prices in Germany--how are they determined?].
Bruhn C
Dtsch Med Wochenschr; 2010 Oct; 135(39):p34. PubMed ID: 20922657
[No Abstract] [Full Text] [Related]
19. Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks.
Gronde TV; Uyl-de Groot CA; Pieters T
PLoS One; 2017; 12(8):e0182613. PubMed ID: 28813502
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceuticals and medical devices: Medicare Part D.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403844
[No Abstract] [Full Text] [Related]
[Next] [New Search]